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Abstract
Rheumatoid arthritis is inherited in a complex manner. So far several single susceptibility genes,
such as PTPN22, STAT4,a n dTRAF1-C5, have been identified. However, it is presumed that some
genes may interact to have a significant effect on the disease, while each of them only plays a
modest role. We propose a new combinatorial association test to detect the gene-gene interaction
in the rheumatoid arthritis data using multiple traits: disease status, anti-cyclic citrullinated peptide,
and immunoglobulin M. Existing gene-gene interaction tests only use the information on a single
t r a i ta tat i m e .I nt h i sa r t i c l e ,w ep r o p o s ean e wm u ltivariate combinatorial searching method that
utilizes multiple traits at the same time. Multivariate combinatorial searching method is conducted
by incorporating the multiple traits with various techniques of feature selection to search for a set
of disease-susceptibility genes that may interact. By analyzing three panels of markers, we have
identified a significant gene-gene interaction between PTPN22 and TRAF1-C5.
Background
Rheumatoid arthritis (RA) has a complex mode of
inheritance that involves the interaction of several genes
and environmental factors. So far, several genes have been
identified as conferring high to modest level of risk to RA,
includingPTPN22 [1],STAT4[2], andTRAF1-C5[3]. Dueto
computational complexity, most association studies evalu-
ate one locus or gene at a time. However, there is evidence
suggesting that gene-gene interaction may play an impor-
tant role in complex disease [4]. To detect genes that may
interact, some methods have been proposed [5,6], but they
only work on a single trait at a time. For a complex disease,
thedataisoftencollectedwithinformationonseveraltraits.
Analyzing the association using multiple traits jointly with
the genotypes may have advantage in improving the power
of the test. Inspired by the combinatorial partitioning [5]
and searching [6] methods, we propose a new combinator-
ial association test incorporating multiple traits to detect
gene-gene interaction in the RA data in Genetic Analysis
Workshop 16 (GAW16) Problem 1. Unlike the methods of
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Open AccessNelson et al. [5] and Sha et al. [6], our test utilizes the
information on multiple traits (disease status, anti-cyclic
citrullinated peptide (anti-CCP) and immunoglobulin M
(IgM)) at the same time. Moreover, to improve computa-
tional efficiency incurred by incorporating multiple traits,
we use the K-mean clustering method to reduce the
dimension, as well as the Akaike’s information criterion
(AIC) to select models.
Methods
Marker selection
We selected 151 single-nucleotide polymorphisms
(SNPs) from the three genes which are mentioned
above. For PTPN22,4 1c o n s e c u t i v eS N P s( f r o m
rs10858004 to rs11485101) in and around the PTPN22
gene were included. The recently reported SNP
rs2476601 (encoding R620W) is the center of the 41
markers that span an interval of more than 400 kb.
rs2476601 is well known to be associated with multiple
autoimmune diseases, including RA [1].
For STAT4, we selected 51 SNPs (from rs883844 to
rs6744978) in STAT1-STAT4 region [2] covering more
than 200 kb. Remmers et al. [2] conducted case-control
analysis and located rs7574865 as the most significant
SNP associated with disease in this region.
In the TRAF1-C5 region on chromosome 9, we tested 59
SNPs (from rs10739575 to rs4837820) that span a
region of about 400 kb covering all the SNPs genotyped
by Plenge et al. [3] and Kurreeman et al. [7]. Plenge et al.
[3] located the most significant SNP rs3761847, and
Kurreeman et al. [7] also confirmed the importance of
the TRAF1-C5 region.
Data cleaning
We removed the SNPs that have only one type of
genotype or with genotype missing rate ≥ 5%. After
genotype imputation (see below “Genotype and pheno-
type imputation”), the data were further filtered based
on minor allele frequency (MAF) < 5% and the p-value of
HWE test <0.001. Finally, 137 SNPs remained.
We also discarded the diseased individuals with missing
anti-CCP or IgM measures. To minimize the effect of
outliers, we removed individuals with anti-CCP ≥ 500 or
IgM ≥ 800. After the above data trimming, 1860
individuals (1194 controls and 666 cases) remained
for analysis.
Genotype and phenotype imputation
Missing genotypes for each SNP were randomly imputed
based on the marginal distribution of the genotypes in
all other individuals.
Becauseallanti-CCPandIgMvaluesaremissingincontrols,
we imputed these two values for each control from a
bivariate normal distribution whose means (11.1 for anti-
CCP and 12 for IgM) and variances (58.5225 and 0.4) are
taken from the existing literatures [8,9]. The correlation
(0.074) between anti-CCP and IgM in controls is assumed
to be the same as in the 666 trimmed cases. After
imputation, the distributions of anti-CCP and IgM in
cases and controls were compared by boxplots (Figure 1).
We found that the imputed trait values successfully
distinguish the cases and controls: there is a large difference
in trait values between cases and controls, and even the
maximum trait values in controls are below the traits’ first
quartile in cases. Moreover, after imputation, the general
correlation between anti-CCP and IgM (combining cases
and controls) is0.117, a little bit larger than 0.074, which is
expected.
The MCSM algorithm
The goal of the multivariate combinatorial searching
method (MCSM) is to identify a set of loci that are
associated with the multiple traits. Suppose that, within
one or several genes, K SNP loci are genotyped. Consider
the subsets of the K SNPs, there are K
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Step 1. Filter all possible L-locus sets
In Step 1, we search all L-locus sets (L = 1,2) and use a filter
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of the total variation in the multiple traits. For a L-locus set
(L =1 ,2 )l e tg1,. . . ,gm+1 denote all the distinct multi-locus
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Consider a multivariate linear regression model:
yxx ii m i m i =+ + + + ββ β ε 01 1 ... , (1)
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T, j =1 ,. . . ,m,a n d
εI =( εi1, εi2, εi3)
T, i =1 ,. . . ,N is a three-dimensional
random vector, independent of the genotypic score Xi
Equivalently, Eq. (1) can be rewritten as
YX B =+ ℑ , (2)
where Y is denoted as above, X =( J, X1, X2, ..., XN)
T and
J is a vector whose elements are 1’s, B =( b0, b1,. . . ,bm)
T
and ℑ =( ε1, ε2,. . . ,εN)
T.
Based on the multivariate model in Eqs. (1) or (2), a
natural choice of filter for screening out the insignificant
SNP loci is an R
2-like measure of association between Y
and X : RS S S S My y y x x x x y
SyxSxx Sxy
Syy
21 1
1
==
−
−− where Syy is
t h es a m p l ec o v a r i a n c em a t r i xo ft h ey values, Sxx is the
s a m p l ec o v a r i a n c em a t r i xo fx values, and Sxy is the
matrix of sample covariance between y values and x
values. However, RM
2 is too small to meaningfully
reflect the amount of association. Therefore, we use r,
the square root of the maximum eigenvalue of
SSSS yy yx xx xy
−− 11 , which is also the largest canonical
correlation between Y and X.W i t h i na l lL-locus sets,
after calculating the r value for each set, we retain the top
10 sets that have the largest r values for future validation
(step 2).
Step 2. Validate and compare the locus-sets retained in Step 1
In Step 2, we validate and compare those locus sets
retained in Step 1. Because m becomes large rapidly as L
increases, K-mean clustering method is used to reduce
the high dimension [6]. Then for a two-locus set (nine
genotypes), we only need evaluate eight (k = 2,3,...,9)
different partitions of the nine genotypes, instead of
21,146 [5]. After partitioning the genotypes into k
groups, denote G1,...,Gk to be the k genotype groups
found by the K-mean clustering method and then
redefine a numerical code for the genotype of the i
th
individual as Xi =( xi,1, ..., xi, k-1), where
x
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In this way, we construct a new multivariate regression
model for each retained locus set, which is similar to Eqs.
(1) or (2). The AIC of the multivariate model is a measure
that indicates the reliability of the model. The small value
of AIC means that the model or the locus set is reliable. For
a specific locus set, the AIC value for each partition is
calculated, and the smallest AIC is chosen as the final value
of the objective function of that locus set:
TA I C k
km
=
≤≤ +
min ( ).
21
At the end of Step 2, the best locus set is chosen as the one
that has the smallest value of the objective function T.
Figure 1
Distributions of anti-CCP and IgM in cases and controls after phenotype imputation.
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To assess the statistical significance of the best locus set
chosen from Step 2, we perform a permutation test.
Denote the objective function (T) value of the best locus
set as T0.I ne a c hp e r m u t a t i o n ,t h et r a i tv e c t o r sy =( y1, y2,
y3)
T of the individuals are randomly permuted, then Step
1 and 2 are repeated on the randomized data. A objective
function (T) value is obtained for each permutation. For
1000 permutations, denote values of the objective
function (T)b yT1, T2,. . . ,T1000.T h eo v e r a l lp-value of
the test for association between the final locus set and
the multiple trait is #{ : } iT i T > 0
1000 .
Data simulation
Before applying the MCSM to the GAW 16 data, the
method was evaluated through simulated data sets. To
assess the type I error, we generated genotypes at ten
independent markers by the MAF (assuming equal MAF
across the ten markers); the phenotype data is the same
as the one used in GAW16. To evaluate the power of
MCSM, we generated both genotype and phenotype data
based on the dichotomous trait in GAW16. Here we
simulated the checkerboard model [6] with two func-
tional SNPs. From the dichotomous trait in GAW16 data
(666 cases and 1194 controls), the genotypes at two
functional SNPs were generated. Then according to the
genotypes at the two functional loci, the two quantitative
traits can be generated [6]. For testing both type I error
and power, 100 replicates with 100 permutations were
conducted, and MAF varied from 0.1 to 0.5.
Results
Simulated data
When the level of significance is 0.05, the type I errors of
the MCSM are 0.05 for an MAF of 0.1 and 0.5,
respectively, and power was 100% for both MAF of 0.1
and 0.5. Thus, when combining multiple traits, the
power of the MCSM is very high.
GAW16 RA data
After implementing MCSM on 1860 individuals with
137 SNPs, we located the best set as a two-locus set:
rs7037673 (TRAF1-C5) and rs2476601 (PTPN22)w i t ha
p-value of 0.031. Table 1 lists the top five two-locus sets
and Table 2 lists the top five single-locus sets as well as
their p-values. As we can see, no single-locus set is
significant, and even the T value of the best single-locus
set is still greater (worse) than the T values of all retained
two-locus sets, which could be evidence of the dom-
inance of joint (gene-gene interaction) effects upon
marginal effects of the candidate genes.
From Table 1, each two-locus set includes rs2476601
(actually, all 25 retained two-locus sets include
rs2476601). Although rs2476601 (PTPN22) is also top-
ranked when only considering marginal effect (Table 2),
it affects the trait variation even more (with a much larger
T value)whenconsideredjointlywithanotherSNP.Three
SNPs in TRAF1-C5, rs17611, rs993247, and rs1951784,
are not significant in single-locussets, but stand out when
interacting with rs2476601 in two-locus sets. rs7037673
(TRAF1-C5) is as active as rs3761847 (TRAF1-C5) in both
single- and two-locus sets. However, we did not get any
evidence supporting rs7574865 (STAT4).
In summary, considering three genes together, TRAF1-C5
and PTPN22 interact significantly, with the best two-
locus set being rs7037673 and rs2476601. In the gene
TRAF1-C5, we discovered SNP rs7037673, which is as
active as rs3761847 in both single-locus and two-locus
sets. However, we did not detect any significant role for
rs7574865 (STAT4).
Discussion
The primary advantage of MCSM is that it utilizes
multiple traits at the same time to detect gene-gene
interactions. However, the computations become inten-
sive due to the trait matrix instead of a trait vector, so we
only considered one-locus and two-locus sets in our
current analysis. To reduce the computational burden,
certain efficient screening statistic or any machine-
learning methods could be used.
The other concern is the validity of our simulated
phenotypes in controls. From the statistical point of
view, we could impute them by empirical parameters,
and our method works well as long as the traits’
distributions in cases and controls largely differ from
each other. However, whether such imputated pheno-
types are reasonable and meaningful in the biological
view still needs further discussion.
Table 1: Top five two-locus sets
SNP 1 (gene) Chr SNP 2 (gene) Chr p-value
rs7037673 (TRAF1-C5) 9 rs2476601 (PTPN22) 1 0.031
rs17611 (TRAF1-C5) 9 rs2476601 (PTPN22) 1 0.058
rs3761847 (TRAF1-C5) 9 rs2476601 (PTPN22) 1 0.067
rs993247 (TRAF1-C5) 9 rs2476601 (PTPN22)1 0 . 0 8
rs1951784 (TRAF1-C5) 9 rs2476601 (PTPN22) 1 0.093
Table 2: Top five single-locus sets
SNP (gene) Chr p-value
rs2476601 (PTPN22) 1 0.942
rs3761847 (TRAF1-C5)9 1
rs7037673 (TRAF1-C5)9 1
rs10760130 (TRAF1-C5)9 1
rs10985073 (TRAF1-C5)9 1
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